Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: New NIRC on '336 may get us back to mid 30's...maybe

That we're limping into the Annual Meeting without a CEO, no definitive sense of where PDSG is going, and no willingness or ability for the BOD to lend clarity on the MMP front or the PDSG front, simply reinforces that this company deserves the 13 cent price tag or lower.

I for one don't see any reason to be in a hurry to find a new CEO until the patents are finished at the USPTO and we see higher and more frequent revenue coming in from the MMP. I don't put much faith in any of the aquisitions or anything the BOD has been in complete control of to this date. We don't need a CEO to collect from the MMP. IMO money needs to be banked for awhile to build a solid foundation for exploring other revenue stream ideas in the future. Perhaps near the end of the life of the patents would be a much better time to invest some of the hundreds of millions of dollars that will have been collected and saved by then from the waves of licenses for the "patents on water".

All the best,

Steve

Share
New Message
Please login to post a reply